The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
TLR2 Is Constitutively Expressed within the Kidney and Participates in Ischemic Renal Injury through Both MyD88-Dependent and -Independent Pathways
Abstract
TLRs are an evolutionarily conserved family of cell membrane proteins believed to play a significant role in innate immunity and the response to tissue injury, including that induced by ischemia. TLR signaling pathways activate transcription factors that regulate expression of prosurvival proteins, as well as proinflammatory cytokines and chemokines through one of two proximal adapter proteins, MyD88 or Toll/IL-1R domain-containing adaptor-inducing IFN-β (Trif). Our study defines the constitutive protein expression of TLR2 in kidneys of humans and mice, and provides insight into the signaling mechanisms by which a deficiency of TLR2 protects from ischemic organ injury. Our study compared and contrasted the effects of renal ischemia in wild-type mice and mice deficient in TLR2, MyD88, Trif, and MyD88 × Trif. TLR2 protein was evident in many cell types in the kidney, including renal tubules of the outer stripe of the medulla, glomeruli, and in the renal vasculature. The pattern of protein expression was similar in humans and mice. The absence of TLR2, MyD88, and MyD88 × Trif conferred both physiologic and histologic protection against sublethal ischemia at 24 h. Interestingly, TLR2-deficient mice were better protected from ischemic renal injury than those deficient for the adapter protein MyD88, raising the intriguing possibility that TLR-2-dependent/MyD88-independent pathways also contribute to kidney injury. We conclude that TLR2 protein is constitutively expressed in the kidney and plays an important role in the pathogenesis of acute ischemic injury by signaling both MyD88-dependent and MyD88-independent pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Molecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684
Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2
Aliprantis, A. O., Yang, R.-B., Mark, M. R., Suggett, S., Devaux, B., Radolf, J. D., Klimpel, G. R., Godowski, P., & Zychlinsky, A. (1999) · Science · doi:10.1126/science.285.5428.736 · Cited by 1,474
Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4
Smiley, S. T., King, J. A., & Hancock, W. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2887 · Cited by 946
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
DAMA, P., LEDOUX, D., NYS, M., VRINDTS, Y., GROOTE, D. D., FRANCHIMONT, P., & LAMY, M. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00009 · Cited by 808
Toll-like receptor 2–mediated NF-κB activation requires a Rac1-dependent pathway
Arbibe, L., Mira, J.-P., Teusch, N., Kline, L., Guha, M., Mackman, N., Godowski, P. J., Ulevitch, R. J., & Knaus, U. G. (2000) · Nature Immunology · doi:10.1038/82797 · Cited by 664
Self-citationTLR Signaling in the Gut in Health and Disease
Abreu, M. T., Fukata, M., & Arditi, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4453 · Cited by 581
Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney
Leemans, J. C., Stokman, G., Claessen, N., Rouschop, K. M., Teske, G. J. D., Kirschning, C. J., Akira, S., van der Poll, T., Weening, J. J., & Florquin, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22832 · Cited by 563
The apoptotic signaling pathway activated by Toll-like receptor-2
Aliprantis, A. O. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3325 · Cited by 503
(1984) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/72.4.955 · Cited by 466
Hoebe, K., Janssen, E. M., Kim, S. O., Alexopoulou, L., Flavell, R. A., Han, J., & Beutler, B. (2003) · Nature Immunology · doi:10.1038/ni1010 · Cited by 446
Wolfs, T. G. A. M., Buurman, W. A., van Schadewijk, A., de Vries, B., Daemen, M. A. R. C., Hiemstra, P. S., & van ’t Veer, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1286 · Cited by 442
Calandra, T., Gerain, J., Heumann, D., Baumgartner, J.-D., & Glauser, M. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90069-a · Cited by 442
Björkbacka, H., Fitzgerald, K. A., Huet, F., Li, X., Gregory, J. A., Lee, M. A., Ordija, C. M., Dowley, N. E., Golenbock, D. T., & Freeman, M. W. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00128.2004 · Cited by 289
Millar, D. G., Garza, K. M., Odermatt, B., Elford, A. R., Ono, N., Li, Z., & Ohashi, P. S. (2003) · Nature Medicine · doi:10.1038/nm962 · Cited by 286
Lack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice
Thurman, J. M., Ljubanovic, D., Edelstein, C. L., Gilkeson, G. S., & Holers, V. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1517 · Cited by 283
Maladaptive Role of IL-6 in Ischemic Acute Renal Failure
Kielar, M. L., John, R., Bennett, M., Richardson, J. A., Shelton, J. M., Chen, L., Jeyarajah, D. R., Zhou, X. J., Zhou, H., Chiquett, B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2003090757 · Cited by 253
Säemann, M. D., Weichhart, T., Zeyda, M., Staffler, G., Schunn, M., Stuhlmeier, K. M., Sobanov, Y., Stulnig, T. M., Akira, S., von Gabain, A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522720 · Cited by 242
Roles of Toll-Like Receptors in C-C Chemokine Production by Renal Tubular Epithelial Cells
Tsuboi, N., Yoshikai, Y., Matsuo, S., Kikuchi, T., Iwami, K.-I., Nagai, Y., Takeuchi, O., Akira, S., & Matsuguchi, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2026 · Cited by 236
Ischemia-Reperfusion Injury Activates Innate Immunity in Rat Kidneys
Kim, B. S., Lim, S. W., Li, C., Kim, J. S., Sun, B. K., Ahn, K. O., Han, S. W., Kim, J., & Yang, C. W. (2005) · Transplantation · doi:10.1097/01.tp.0000158355.83327.62 · Cited by 189
Ritter, M., Mennerich, D., Weith, A., & Seither, P. (2005) · Journal of Inflammation · doi:10.1186/1476-9255-2-16 · Cited by 184
Patel, N. S. A., Chatterjee, P. K., Di Paola, R., Mazzon, E., Britti, D., De Sarro, A., Cuzzocrea, S., & Thiemermann, C. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078659 · Cited by 176
Toll‐Like Receptor and Heme Oxygenase‐1 Signaling in Hepatic Ischemia/Reperfusion Injury
Shen, X., Ke, B., Zhai, Y., Gao, F., Busuttil, R. W., Cheng, G., & Kupiec‐Weglinski, J. W. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00932.x · Cited by 171
TLRs Regulate the Gatekeeping Functions of the Intestinal Follicle-Associated Epithelium
Chabot, S., Wagner, J. S., Farrant, S., & Neutra, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4275 · Cited by 158
Li, C. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.007 · Cited by 156
Threat matrix: Low-molecular-weight hyaluronan (HA) as a danger signal
Powell, J. D., & Horton, M. R. (2005) · Immunologic Research · doi:10.1385/ir:31:3:207 · Cited by 142
Strassheim, D., Asehnoune, K., Park, J.-S., Kim, J. Y., He, Q., Richter, D., Kuhn, K., Mitra, S., & Abraham, E. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5727 · Cited by 141
Ischemia/Reperfusion-Induced IFN-γ Up-Regulation: Involvement of IL-12 and IL-18
Daemen, M. A. R. C., Veer, C. V. ′., Wolfs, T. G. A. M., & Buurman, W. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5506 · Cited by 122
Expression of cytokine-like genes JE and KC is increased during renal ischemia
Safirstein, R. L., Megyesi, J., Saggi, S. J., Price, P. M., Poon, M., Rollins, B. J., & Taubman, M. B. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.261.6.f1095 · Cited by 117
New Players in TLR-Mediated Innate Immunity: PI3K and Small Rho GTPases
Ruse, M., & Knaus, U. G. (2006) · Immunologic Research · doi:10.1385/ir:34:1:33 · Cited by 105
DeMarco, R., Fink, M. P., & Lotze, M. T. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.023 · Cited by 101
Schreiner, B., Voss, J. G., Wischhusen, J., Dombrowski, Y., Steinle, A., Lochmüller, H., Dalakas, M. C., Melms, A., & Wiendl, H. (2005) · The FASEB Journal · doi:10.1096/fj.05-4342fje · Cited by 96
Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes
Frost, R. A., Nystrom, G. J., & Lang, C. H. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00490.2005 · Cited by 96
Innate immune recognition of nucleic acids: Beyond toll-like receptors
Ishii, K. J., & Akira, S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21402 · Cited by 67
Teusch, N. E., Lombardo, E., Eddleston, J., & Knaus, U. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.507 · Cited by 64
Frank, R. D., Schabbauer, G., Holscher, T. D., Sato, Y. Z., Tencati, M., Pawliński, R., & Mackman, N. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01188.x · Cited by 51
Self-citationTLRs play good cop, bad cop in the lung
O'Neill, L. A. J. (2005) · Nature Medicine · doi:10.1038/nm1105-1161 · Cited by 51
Maślińska, D., Laure‐Kamionowska, M., & Maśliński, S. (2004) · PubMed · Cited by 39
Ojaniemi, M., Vähä-Mäkilä, M., Harju, K., Sormunen, R. T., Vuolteenaho, R., & Hallman, M. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.08.009 · Cited by 37
Beutler, B., & Hoffmann, J. A. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.017 · Cited by 15
The Toll Receptor Family: From Microbial Recognition to Seizures
Vezzani, A. (2006) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2005.00080.x · Cited by 3
Cited by
Ischaemia–reperfusion injury in liver transplantation—from bench to bedside
Zhai, Y., Petrowsky, H., Hong, J. C., Busuttil, R. W., & Kupiec-Weglinski, J. W. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.225 · Cited by 843
Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps
Rabb, H., Griffin, M. D., McKay, D. B., Swaminathan, S., Pickkers, P., Rosner, M. H., Kellum, J. A., & Ronco, C. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030261 · Cited by 583
Self-citationLinking oxidative stress to inflammation: Toll-like receptors
Gill, R., Tsung, A., & Billiar, T. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.006 · Cited by 553
Mediators of Inflammation in Acute Kidney Injury
Akcay, A., Nguyen, Q., & Edelstein, C. L. (2009) · Mediators of Inflammation · doi:10.1155/2009/137072 · Cited by 518
Extracellular Histones Are Mediators of Death through TLR2 and TLR4 in Mouse Fatal Liver Injury
Xu, J., Zhang, X., Monestier, M., Esmon, N. L., & Esmon, C. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003930 · Cited by 507
Metadata
- Authors
- Shigeoka, A. A., Holscher, T. D., King, A. J., Hall, F. W., Kiosses, W. B., Tobias, P. S., Mackman, N., & McKay, D. B.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05
- Volume
- 178
- Issue
- 10
- Pages
- 6252-6258
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1940749453
- Cited by
- 273
- References
- 43
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.